Tectonic Therapeutic (TECX) Depreciation & Amortization (CF) (2017 - 2026)

Tectonic Therapeutic's (TECX) quarterly Depreciation & Amortization (CF) came in at $304000.0 in Q1 2026, down 15.56% year-on-year from $360000.0 in Q1 2025, and down 8.71% on a QoQ basis from $333000.0 in Q4 2025.

Tectonic Therapeutic (TECX) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

Tectonic Therapeutic (TECX) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $304000.0 in Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 15.56% year-over-year to $304000.0 in Q1 2026; TTM through Mar 2026 was $1.3 million, a 18.98% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, down 16.41% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $304000.0, down from $333000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for TECX reached as high as $508000.0 in Q4 2024 and fell as low as $289000.0 in Q2 2023.
  • Historically, Depreciation & Amortization (CF) has averaged $359352.9 across 5 years, with a median of $342000.0 in 2025.
  • Across the five-year window, Depreciation & Amortization (CF) surged 37.11% in 2022 and plunged 34.45% in 2025, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $335000.0 in 2022, then climbed by 11.34% to $373000.0 in 2023, then surged by 36.19% to $508000.0 in 2024, then slumped by 34.45% to $333000.0 in 2025, then decreased by 8.71% to $304000.0 in 2026.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $304000.0 in Q1 2026, $333000.0 in Q4 2025, and $342000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Tectonic Therapeutic 595.23 Mn 595.23 Mn - 304,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 304,000.00
Mar 31, 2026 304,000.00
Dec 31, 2025 333,000.00
Dec 31, 2025 333,000.00
Sep 30, 2025 342,000.00
Sep 30, 2025 342,000.00
Jun 30, 2025 340,000.00
Jun 30, 2025 340,000.00
Mar 31, 2025 360,000.00
Mar 31, 2025 360,000.00
Dec 31, 2024 508,000.00
Dec 31, 2024 508,000.00
Sep 30, 2024 424,000.00
Sep 30, 2024 424,000.00
Jun 30, 2024 336,000.00
Jun 30, 2024 336,000.00
Mar 31, 2024 377,000.00
Mar 31, 2024 377,000.00
Dec 31, 2023 373,000.00
Dec 31, 2023 373,000.00